MENDOCINO CO., 7/15/25 – A Willits man who died last month after Mendocino County Sheriff’s Office personnel used pepper ...

New Phase II data presented at ENDO 2025 highlight avexitide’s potential to significantly reduce severe hypoglycemic events ...

Klamath River ss newly navigable after a decades-long fight to remove its four dams to restore the salmon run.

SAN FRANCISCO -- Age of menarche may provide several insights on long-term cardiometabolic and reproductive health, a ...

SAN FRANCISCO -- The investigational selective glucocorticoid receptor modulator relacorilant led to improvements in blood ...

A recent research presented at the ENDO 2025 revealed that high blood sugar levels can impact men's sexual health. The ...

Mukbang, a South Korean trend where people consume large amounts of food on camera, has gone global. Now some diet experts ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

HealthDay News — From 1999 to 2020, obesity-related cancer mortality increased significantly, according to a study presented at ENDO 2025, the annual meeting of the Endocrine Society, held from July ...

The menopause transition offers a valuable opportunity to forecast a woman’s health risks, but clinicians should also prepare ...

Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) is one of the best low priced pharma stocks to buy now. On July 13, Amylyx Pharmaceuticals announced new exploratory analyses from its Phase 2 PREVENT and ...

Researchers found that pairing tirzepatide with hormone therapy boosts weight loss success in postmenopausal women—up to 17% ...